BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23725144)

  • 1. Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer.
    Fu JH; Gao Z; Ren CC; Shi YG
    Asian Pac J Cancer Prev; 2013; 14(4):2377-81. PubMed ID: 23725144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
    Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
    Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?
    Kuku S; Proctor I; Loddo M; Kadalayil L; KhoshZaban M; Ledermann J; McCormack M
    Int J Gynecol Cancer; 2015 Jul; 25(6):1066-72. PubMed ID: 25621411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.
    Sakuragi N; Kato T; Shimada C; Kaneuchi M; Todo Y; Mitamura T; Takeda M; Kudo M; Murakami G; Watari H
    JAMA Netw Open; 2020 May; 3(5):e204307. PubMed ID: 32379332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Benefit of Induction Chemotherapy with Paclitaxel and Carboplatin Followed by Chemoradiation Versus Postoperative Treatment in Locally Advanced Gastric Cancer: A Retrospective Cohort Study.
    Azadeh P; Gholizadeh Pasha S; Yaghobi Joybari A; Abiar Z; Alahyari S; Taghizadeh-Hesary F
    J Gastrointest Cancer; 2024 Mar; 55(1):457-466. PubMed ID: 38010493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
    Abou-Taleb HA; Koshiyama M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Abiko K; Yamanoi K; Murakami R; Horikawa N; Taha AA; Kitamura S; Konishi I
    J Int Med Res; 2016 Apr; 44(2):346-56. PubMed ID: 26831404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer.
    Tao W; Wang W; Zhai J; Guo L
    Med Sci Monit; 2023 Dec; 29():e940545. PubMed ID: 38062672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
    BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature.
    Liu L; Deng X; Guo S; Yang S
    Diagn Pathol; 2023 Sep; 18(1):107. PubMed ID: 37752528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
    Cheng J; Liu B; Wang B; Long X; Li Z; Chen R; Wu R; Xu L
    BMC Cancer; 2021 Oct; 21(1):1078. PubMed ID: 34615494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Combined Neoadjuvant Chemotherapy and Vitamin A in Advanced Cervical Carcinoma: A Randomized Double-Blind Clinical Trial.
    Sanusi RS
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2213-2218. PubMed ID: 31350987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perineural invasion in cervical cancer: A multicenter retrospective study.
    Chen X; Duan H; Zhao H; He F; Yin L; Liu Y; Wang L; Chen C
    Eur J Surg Oncol; 2024 Jun; 50(6):108313. PubMed ID: 38579659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
    Liu Y; Xin W; Wang P; Ji M; Guo X; Ouyang Y; Zhao D; Hua K
    J Gynecol Oncol; 2024 May; 35(3):e81. PubMed ID: 38522951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neoadjuvant chemotherapy followed by surgery for FIGO stage I-II cervical cancer: a meta-analysis.
    Yang SL; Chen L; He Y; Zhao H; Wu YM
    J Int Med Res; 2020 Aug; 48(8):300060520945507. PubMed ID: 32867558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Center 18-Year Series of 73 Cases of Metaplastic Carcinoma of the Breast.
    Thériault K; Ben Moussa M; Perron M; Desbiens C; Poirier B; Poirier É; Leblanc D; Morin C; Lemieux J; Hogue JC; Boudreau D
    Breast J; 2024; 2024():5920505. PubMed ID: 38223556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
    Wu J; Wang R; Chen W; Wu Y; Xiao L
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy combined with surgery for the treatment of a rare primary vaginal adenocarcinoma.
    Liu S; Li M; Zhang H
    Asian J Surg; 2024 Apr; 47(4):2039-2040. PubMed ID: 38220528
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation.
    Hui C; Ewongwo A; Lau B; Fisher G; Delitto D; Poultsides G; Ho QA; Rahimy E; Pollom E; Chang DT; Vitzthum LK
    Ann Surg Oncol; 2024 Jan; 31(1):413-420. PubMed ID: 37755563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there finally a place for neoadjuvant treatment in locally advanced cervical cancer?
    Pautier P
    Lancet Oncol; 2024 Jan; 25(1):5-6. PubMed ID: 38048801
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience.
    Algin E; Esen SA; Acikgoz Y; Bal O
    J Cancer Res Ther; 2023 Oct; 19(7):2018-2024. PubMed ID: 38376312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.